Loading clinical trials...
Loading clinical trials...
The specific immune response to SARS-CoV-2 includes a humoral response - specific IgM appearing 5 days after the onset of symptoms while IgG appears after 14 days - and a T lymphocyte component, with ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Versailles Hospital
NCT05909059 · Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, and more
NCT06156774 · Non-hodgkin Lymphoma,B Cell
NCT05741359 · Non-hodgkin Lymphoma,B Cell
NCT06838832 · Non-hodgkin Lymphoma,B Cell
NCT05266664 · Immune System Disorder, Preterm, and more
Emile Muller Hospital, Hematology unit
Mulhouse
Institut of Cancerology Strasbourg Europe (ICANS), Hematology deparment
Strasbourg
Hospitals of Brabois, Hematology unit
Vandœuvre-lès-Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions